Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study - Concepedia

Concepedia

Publication | Open Access

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

DOI Full Paper Access

319

Citations

17

References

2018

Year

Shirish M. Gadgeel, Solange Peters, Tony Mok, Alice T. Shaw, D.W. Kim, Sai‐Hong Ignatius Ou, M. Pérol, Anna Wrona, Silvia Novello, Rafael Rosell,

Annals of Oncology

References

	Year	Citations

Page 1